Parker Institute board member named President-elect of the American Association for the Advancement of Science

The American Association for the Advancement of Science (AAAS) recently announced the appointment of Margaret Hamburg as their president-elect. Hamburg is and has been a firm advocate in the role that science plays in our lives today as well as in the future.

While the potential is enormous for new discoveries in science that can greatly impact people’s lives, Hamburg stresses that new discoveries must be analyzed and acted upon quickly. She also feels strongly that educating others about the role that science plays is important.

She has personally advocated for less tobacco use and increased food safety procedures. Hamburg is also a board member of the Parker Institute for Cancer Immunotherapy research. Jeffrey Bluestone, Ph.D, President and CEO of Parker Institute for Cancer Immunotherapy said, “Peggy’s deep knowledge and experience in science, health care and regulatory affairs has been invaluable as we push the boundaries in cancer immunotherapy research,”. In addition, he feels confident of her ability to provide strong strategic direction to the Parker Institute.

The Parker Institute works tirelessly to find breakthrough immune therapies that have the ability to turn cancer into a curable disease. They do so by utilizing research findings of top researchers in the field and converting them into groundbreaking patient treatment plans.

Currently, the Parker Institute network consists of six treatment centers and more than 40 nonprofit as well as industry partners. They also represent 300 of the country’s top researchers in the field whose focus is on eradication of some of today’s deadliest cancers.

Dr. Hamburg brings with her an impressive resume of experience, including being the former commissioner of the U.S. Food and Drug Administration. Prior to that, Dr. Hamburg served as vice president and senior scientist at the Nuclear Threat Initiative.

The Parker Institute is an unrivaled collaboration of the country’s leading cancer centers and experts. The greatest minds in science, research, immunology, and cancer medicine partner together to provide cutting-edge technology for today’s patients.